Log In
Print this Print this

99mTc-MIP-1404 (1404, F-1311) (formerly 99mTc-trofolostat)

  Manage Alerts
Collapse Summary General Information
Company Progenics Pharmaceuticals Inc.
DescriptionTechnetium-99m-labeled small molecule targeting prostate-specific membrane antigen (PSMA; FOLH1; GCPII)
Molecular Target Prostate-specific membrane antigen (PSMA) (FOLH1) (GCPII)
Mechanism of ActionDiagnostic; Imaging agent
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentPhase II
Standard IndicationCancer, Diagnostic
Indication DetailsDetect prostate cancer
Regulatory Designation
Partner Fujifilm Holdings Corp.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today